PATENT CLAIM ANALYSIS

Application Number: 15975130
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "171000"]

Abstract:
The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for Trk-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease. A compound represented by the general formula (I), wherein all symbols represent the same meanings as described in the specification, a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having Trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.

Claim (Index 7):
The compound according to  claim 1 , wherein the ring Cy 1  represents a benzene ring or a 5- to 6-membered monocyclic aromatic heterocycle.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.89231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14768727', '15173161', '15679568', '15291700', '15504514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9034527958627496
- 35 USC 102 Novelty (BERT): 0.5907237348501885
- Combined Prediction Score: 0.8721798897614935
- Mean Citation Score: 805.8718299999997
- Max Citation Score: 932.92145
- Similarity Product: 445.98123030638845

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test